Affinity DataKi: 8nM ΔG°: -43.0kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: 8nMAssay Description:Displacement of [3H]Rosiglitazone from human PPARgammaMore data for this Ligand-Target Pair
Affinity DataKi: 18nMAssay Description:Displacement of [3H]Rosiglitazone from human PPARgammaMore data for this Ligand-Target Pair
Affinity DataKi: 18nMAssay Description:Displacement of [3H]Rosiglitazone from human PPARgammaMore data for this Ligand-Target Pair
Affinity DataKi: 18nMAssay Description:Displacement of [3H]rosiglitazone from human PPARgamma receptorMore data for this Ligand-Target Pair
Affinity DataKi: 18.4nMAssay Description:Displacement of [3H]rosiglitazone from human PPARgamma receptorMore data for this Ligand-Target Pair
Affinity DataKi: 33nMAssay Description:Displacement of [3H]rosiglitazone from human PPARgamma receptorMore data for this Ligand-Target Pair
Affinity DataKi: 48nMAssay Description:Displacement of [3H]Rosiglitazone from human PPARgammaMore data for this Ligand-Target Pair
Affinity DataKi: 54nMAssay Description:Displacement of [3H]rosiglitazone from human PPARgamma receptorMore data for this Ligand-Target Pair
Affinity DataKi: 54.2nMAssay Description:Displacement of [3H]rosiglitazone from human PPARgamma receptorMore data for this Ligand-Target Pair
Affinity DataKi: 89nMAssay Description:Displacement of [3H]Rosiglitazone from human PPARgammaMore data for this Ligand-Target Pair
Affinity DataKi: 254nMAssay Description:Displacement of [3H]rosiglitazone from human PPARgamma receptorMore data for this Ligand-Target Pair
Affinity DataKi: 378nM ΔG°: -34.1kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: 583nM ΔG°: -33.1kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: 618nMAssay Description:Displacement of [3H]Rosiglitazone from human PPARgammaMore data for this Ligand-Target Pair
Affinity DataKi: 947nM ΔG°: -32.0kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: 1.93E+3nM ΔG°: -30.3kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: 3.81E+3nM ΔG°: -28.8kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]rosiglitazone from human PPARgamma receptorMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]rosiglitazone from human PPARgamma receptorMore data for this Ligand-Target Pair
Affinity DataKi: 1.00E+4nMAssay Description:Displacement of [3H]Rosiglitazone from human PPARgammaMore data for this Ligand-Target Pair
Affinity DataKi: 1.00E+4nMAssay Description:Displacement of [3H]Rosiglitazone from human PPARgammaMore data for this Ligand-Target Pair
Affinity DataKi: 1.00E+4nMAssay Description:Displacement of [3H]Rosiglitazone from human PPARgammaMore data for this Ligand-Target Pair
Affinity DataKi: 1.00E+4nMAssay Description:Displacement of [3H]Rosiglitazone from human PPARgammaMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-26.5kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-26.5kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-26.5kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-26.5kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-26.5kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-26.5kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-26.5kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-26.5kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-26.5kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-26.5kJ/molepH: 8.2 T: 2°CAssay Description:Binding assays were performed in 96-well plate format, using a classical filtration assay with a human full length PPARγ construct (GST-PPAR LBD...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 189nMAssay Description:Agonist activity at human PPARalpha by GAL4 transactivation assayMore data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 414nMAssay Description:Agonist activity at human PPARalpha by GAL4 transactivation assayMore data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 7.90nMAssay Description:Agonist activity at human PPARalpha at 100 uM by GAL4 transactivation assay relative to WY 14,643More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 1.00E+4nMAssay Description:Agonist activity at human PPARalpha by GAL4 transactivation assayMore data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 12nMAssay Description:Agonist activity at human PPARalpha by GAL4 transactivation assayMore data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 37nMAssay Description:Agonist activity at human PPARalpha at 100 uM by GAL4 transactivation assay relative to WY 14,643More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 19nMAssay Description:Agonist activity at human PPARalpha at 100 uM by GAL4 transactivation assay relative to WY 14,643More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 65nMAssay Description:Agonist activity at human PPARalpha at 100 uM by GAL4 transactivation assay relative to WY 14,643More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 14nMAssay Description:Agonist activity at human PPARalpha at 100 uM by GAL4 transactivation assay relative to WY 14,643More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 29nMAssay Description:Agonist activity at human PPARalpha by GAL4 transactivation assayMore data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 194nMAssay Description:Agonist activity at human PPARalpha by GAL4 transactivation assayMore data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 30nMAssay Description:Agonist activity at human PPARalpha by GAL4 transactivation assayMore data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 4nMAssay Description:Agonist activity at human PPARalpha at 100 uM by GAL4 transactivation assay relative to WY 14,643More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 195nMAssay Description:Agonist activity at human PPARalpha at 100 uM by GAL4 transactivation assay relative to WY 14,643More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 11nMAssay Description:Agonist activity at human PPARalpha at 100 uM by GAL4 transactivation assay relative to WY 14,643More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor alpha(Homo sapiens (Human))
Spot-Ea3857
Curated by ChEMBL
Spot-Ea3857
Curated by ChEMBL
Affinity DataEC50: 152nMAssay Description:Agonist activity at human PPARalpha at 100 uM by GAL4 transactivation assay relative to WY 14,643More data for this Ligand-Target Pair